Boston Scientific (BSX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2025 investor letter. A ...

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at ...

This Zacks Rank #4 (Sell) stock is expected to report earnings decline of 6.7% in 2025 on a 2.5% revenue increase.

We note that Boston Scientific Corporation (NYSE:BSX) does have debt on its balance sheet. But the more important question is: how much risk is that debt creating? We've found 21 US stocks that ...

Abbott, a Zacks Rank #3 stock, is expected to report earnings growth of 10.5% on revenue growth of 6.5% in 2025. Boston Scientific's first-quarter 2025 adjusted EPS increased 33.9% year over year ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Also that day, Marlborough-based Boston Scientific chief executive Michael Mahoney forecast a $200 million hit to his company from the tariffs this year. As a result, BSX is cutting back on ...